All News

This new study from Spain represents the first extensive look at late presentation of persons living with HIV, following the 2014 introduction of guidelines on early HIV diagnosis.

A lack of consensus for the term “immunocompromised” suggests that studies demonstrating the effectiveness of infection prevention in surgical patients at a high risk of wound infection may have limited relevancy.

A long-term Swedish study found that nonalcoholic fatty liver disease (NALFD) significantly increased mortality in children and young adults, particularly due to cancer, cardiometabolic disease, and liver disease.

An algorithm influenced by cough sound recognition and symptom reporting conducted using a smartphone was found to be effective at diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Psoriasis is prevalent among more than 7.5 million adults in the United States, a new study says.

The findings, coming from nearly a decade’s worth of retrospective data on patients aged at least 65 years, offer real-world evidence on the treatment’s impact on survival.

Moderna starts testing for its new mRNA seasonal flu vaccine; the worldwide COVID-19 death toll hits 4 million as Delta variant spreads; more states sign on to Purdue Pharma's bankruptcy reorganization plans after additional payments and release of documents are added to the deal.

Children exposed to environmental stressors known to impair sleep exhibited improved sleep duration by more than 1 hour each night after undergoing a mindfulness training intervention program, with rapid-eye movement sleep improving as well.

A meta-analysis from ESC Heart Failure shows the effects of home telemonitoring in patients with decompensated heart failure.

Twenty-eight patient advocacy groups wrote a letter pledging endorsement of the Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act, a bill aimed at increasing reimbursement and incentivizing prescriptions for biosimilars.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

Christopher Arendt, PhD, head, Oncology Therapeutic Area Unit, Takeda, speaks on the efficacy data of mobocertinib in patients with EGFR exon 20 mutations within metastatic non–small cell lung cancer (NSCLC) and its potential significance for these patient populations.

Meena Seshamani, MD, PhD, is named deputy administrator and director of Center for Medicare; United States falls short of President Joe Biden’s Independence Day vaccination goal, with large variation between state vaccination rates; study finds those who smoke menthol cigarettes have more trouble quitting than those who smoke unflavored cigarettes.

Despite positive data showing that negative pressure wound therapy (NPWT) can help accelerate wound healing for neck and head wounds, investigators of a review found that the presence of certain comorbidities may slow healing times.

A statement from the makers of the SGLT2 inhibitor empagliflozin suggests the benefits in heart failure with preserved ejection fraction (HFpEF) are significant.

Mary Pat Gallagher, MD, of NYU Langone Health, discusses research needed to better understand how COVID-19 impacts individuals with diabetes.

Low-dose niacin uptake over 12 months was associated with improvements in the UPDRS III motor score, as well as fatigue and mood in people with Parkinson disease.

Data from several surveys conducted since 2005 indicate a continuous gap in HIV prevention and transmission between adolescent females and males in sub-Saharan Africa.

This episode of Managed Care Cast features interviews with experts who discuss how the same efforts to stamp out COVID-19 also reduced Clostridioides difficile and the prospects for such mitigation efforts to continue.

Results of an online survey indicated that remote electrical neuromodulation (REN) may serve as a nonpharmocological treatment option for patients with menstrual migraine.

Robin Gelburd, JD, details the dip in telehealth claims observed during April 2021.

The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.

Ambulance response services in rural communities face increasing recruitment and expense burdens; data from Israel show a decline in Pfizer/BioNTech COVID-19 vaccine efficacy in preventing symptomatic SARS-CoV-2 infection; the US Supreme Court will hear a case on 340B drug payment cuts.

The Medicare Access and CHIP Reauthorization Act (MACRA) needs to be reimagined get back on track and to live up to its promise to incentivize value-based care.

The researchers outlined patient selection for treatment, adverse event management, and future strategies for the treatment of these patients.

Data from IMpower 130, IMpower 132, and IMpower 150 confirm that combining atezolizumab with chemotherapy is the best first-line treatment in advanced NSCLC when anti-PD-L1 therapy is indicated.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist at Geisinger, discusses biologic, lifestyle, and pandemic-related factors associated with poor sleep quality in adolescents.

Health insurance companies are anticipating a swell in pent-up demand for delayed or forgone health services in 2020, as well as increased costs associated with distributing COVID-19 vaccines to millions of Americans. To offset the potentially precarious business impact caused by these converging factors, insurers are turning to technology for help.